Transcript Slide 1


Causes
◦ Idiopathic/allergic/autoimmune
◦ Neoplasia
◦ Viral
◦ Fungal
◦ Primary bacterial - Rare
◦ Foreign body
◦ Parasitic

Clinical signs/physical exam
◦ Sneezing typically first sign
 May be seasonal/intermittent and chronic
◦ Nasal discharge
 Serous Mucopurulent Hemorrhagic
◦ Cough/gag
o Nasal pain
o Ocular retropulsion
o Airflow present?
o Stertor

Localization of nasal discharge
◦ Unilateral
 Neoplasia
 Fungal
 Foreign body
 Idiopathic/allergic/chronic rhinitis
 Systemic disease – Coagulopathy, pneumonia
◦ Bilateral
 Idiopathic/allergic/chronic rhinitis
 Systemic disease - Coagulopathy, pneumonia
 Fungal +/-

Epistaxis
◦ Local disease
 Neoplasia
 Fungal
 Chronic idiopathic rhinitis
◦ Systemic disease
 Thrombocytopenia
 Hypertension
 Hyperviscosity
 Vasculitis

Initial work-up
◦ General bloodwork
◦ Thoracic radiographs
◦ +/- skull radiographs
◦ +/- cytology
◦ Coagulation profile
◦ Blood pressure if epistaxis present

Initial work-up
◦ Culture?
◦ Sedated oral exam
 Use spay hook and good light source
 Deep sedation sometimes necessary
 Maxillary 3rd incisor and premolars 1, 2, 3 (mesial
root)
 Dental probe indicated in many cases

Advanced work-up
◦ CT scan
◦ MRI scan
◦ Rhinoscopy and biopsy
◦ Blind biopsy

CT scan
◦ Always image nasal passages prior to biopsy
◦ Best for detailed evaluation of nasal passages and
frontal sinus
◦ Differentiation of inflammation, fungal, neoplasia
◦ Use iodinated contrast

Rhinoscopy
◦ Practice, practice, practice!
 Use CT to guide biopsies in many cases
 Always biopsy both sides
 Guided biopsy combined with and followed by
“blind” sampling is preferred

Rhinoscopy
◦ Posterior/retroflexion
 Useful for identification of unusual causes of nasal
discharge or stertor (esp. cats)
 Removal of inspissated discharge can be therapeutic
 Biopsy of lesions may be difficult
 3.9mm or 8.6mm flexible scope
◦ Anterior – rigid scope
 Often limited visualization even with much experience
 2.7mm rigid scopes (4, 10mm may be used)

Blind biopsy
◦ Indicated in cases with financial limitations
◦ Accuracy of samples must always be questioned
◦ Procedure
 Sedated with intubation mandatory
 Pack throat
 Have epinephrine on hand
 Obtain samples from both sides

Aspiration may be considered if externally visible
mass

Limitations of all nasal biopsies
◦ Inflammation surrounding masses
◦ Differentiating neoplasia from true/primary
◦ Owners should always be made aware of:
 Potential need to repeat scope and biopsy if biopsy
results do not coincide with physical exam, imaging
findings, or clinical impressions
 Rhinoscopy and biopsy procedures are rarely, if ever
therapeutic!!

Cytology
◦ Indicated for cats with nasal discharge and clinical
suspicion of fungal disease
◦ Not useful for diagnosis of neoplasia, idiopathic
rhinitis, fungal rhinitis in dogs, or true bacterial
infection
◦ Brush cytology generally does not correlate with
biopsy results

Nasal culture
◦
◦
◦
◦
Fairly useless in most cases
False positive for fungal and bacterial infection
False negative often found in dogs with Aspergillosis
Mainly indicated in cats with chronic rhinitis/nasal
discharge and dogs with non-responsive to therapy for
“chronic rhinitis”

Fungal rhinitis
◦ Potential pathogens
 Aspergillosis
 Rhinosporidium seeberi
 Penicillium
◦ Differentiating signs
 Dramatic
 Depigmentation and nasal pain (tip of nose)
 Severe turbinate loss on CT or radiographs
 Fungal plaques seen on rhinoscopy
 Typically unilateral

Fungal rhinitis
◦ Serology and fungal culture are not sensitive or
specific
◦ Empirical therapy may be considered if:
 Nasal depigmentation
 Nasal pain
 Positive serology
 Owner refuses or cannot afford rhinoscopy

Fungal rhinitis
◦ CT scan/radiographs
 Severe turbinate loss
 Fluid/granuloma opacity in nasal passage and
possibly frontal sinus
 +/- bone erosion
 +/- erosion of cribiform plate
◦ Histopathology
 Generally sensitive for obvious infection, but can
miss in presence of severe inflammation

Fungal rhinitis
◦ Rhinoscopy
 Severe turbinate loss in most (too much room!)
 Friable mucosa, erythema, hyperemia, edema
 White fungal plaques
 Seen in 83% of cases within the nasal cavity
 17% localized exclusively in sinus(‘)
 Need ability to reach sinus for this reason as well
as for catheter placement during therapy
 Very time consuming during therapeutic phase $$$

Fungal rhinitis
◦ Rhinoscopic topical therapy best
 Enilconazole 1% (nasal) and 2% (sinus), compared to
1% clotrimazole infusion
 May have long term nasal signs following infusion
with both treatments
 Approximately 50% of the time
 Typically antibiotic responsive
 Discouraged, but can be done if cribiform plate is not
intact
From Peeters, D. and Clerx C., Update on Canine Sinonasal Aspergillosis.
Vet Clin North Am Small Anim Pract 2007; 37 (5): 909.

Fungal rhinitis therapy
◦
◦
◦
◦
Meticulous debridement
Follow-up rhinoscopy
Combine with oral antifungals?
Surgery
 For inaccessible suspected sinus infection
 Clotrimazole liquid topical combined with cream
instillation as depot therapy

Oral antifungal therapy
◦
◦
◦
◦
Oral therapy alone is not recommended
Use if cribiform plate is not intact
Reported 50-70% cure rate (best case scenario)
Options (best to worst)
 Itraconazole 5mg/kg BID X 10 weeks
 Fluconazole 2.5mg/kg BID X 10 weeks
 Ketoconazole 5mg/kg BID 12 weeks
 Thiabendazole 10mg/kg BID X 6-8 weeks
 Terbinafine 5-10mg/kg BID X 10 weeks
◦ Cost, GI side effects, and hepatotoxicity

Lymphoplasmacytic rhinitis
◦ Fairly common disease of dogs
◦ Diagnosis may obtained with other underlying causes
 Fungal
 Foreign body
 Neoplasia
 Parasitic
 Mites
 True bacterial infection

Lymphoplasmacytic rhinitis
◦ Causes
 Idiopathic
 Inhaled allergens
 Irritants
 Hypersensitivity to bacteria or fungi?
 Dust mites? (n=3)

Lymphoplasmacytic rhinitis radiographic findings
 Turbinate destruction
 Soft tissue/fluid opacity
 Obvious bone lysis/remodeling
◦ CT findings
 May be difficult for differentiation of inflammation
from neoplasia in cats, but fairly good in dogs
 Allows clinician to target biopsy collection from
areas of interest
 Turbinate destruction can mimic fungal rhinitis
 Fluid in nasal passages and sinuses
 Suspect fungal disease or neoplasia if bone
destruction noted

Lymphoplasmacytic rhinitis
◦ Rhinoscopy
 Erythema, hyperemia, edema, normal
 Not sensitive for detection of turbinate destruction
 Right and left sides may differ on gross inspection
considerably, but disease present on both sides in
most
◦ Histopathology
 Biopsy results may not correlate with disease
severity or clinical signs
 Always correlate with imaging findings

Lymphoplasmacytic rhinitis
◦ Therapy – General considerations
 FRUSTRATING!!!!!
 Owner preparation is critical if suspected diagnosis
 No cure, but hope to decrease signs to acceptable
level
 Lifelong treatment often required
 Seasonal or unpredictable relapse is common
 Allergen avoidance
 Smoke, forced air heat, wood burning stoves,
fireplace, etc.

Lymphoplasmacytic rhinitis
◦ Drug therapy
 Antihistamines
 Many formulations, but none evaluated critically
 Sometimes effective but durable response rarely
achieved
 Oral corticosteroids
 Prednisone 0.5-1mg/kg BID to start with taper over 2-3
weeks
 Use at beginning of combined therapeutic regimen in
selected cases
 Only in those with serous discharge
 Generally poor response overall esp. when used alone

Lymphoplasmacytic rhinitis - Therapy
◦ Antibiotic therapy
 Combine with oral or topical anti-inflammatory
therapy
 Doxycycline 3-5mg mg/kg BID X 2 weeks
 Reduce to once daily if responsive
 Azithromycin 10mg/kg daily 5 days
 Reduce to 2X/week if initially responsive
 Use at standard dose intermittently or alternative
antibiotic based on C & S if persistent purulent or
mucopurulent discharge noted

Lymphoplasmacytic rhinitis - Therapy
◦ Oral antiinflammatory therapy
 Oral corticosteroids
 Prednisone 0.5-1mg/kg BID to start with taper
over 2-3 weeks
 Use at beginning of combined therapeutic regimen
in selected cases
 Only in those with serous discharge
 Generally poor response overall esp. when used
alone
 NSAIDs - Piroxicam 0.3mg/kg daily
 Use with misoprostol 3mcg/kg (2-5mcg/kg) BID
◦ Topical antiinflammatory therapy
 Flovent 110-220mcg/actuation BID to start
 May reduce to once daily or every other day if
effective
 Lower to once daily if significant improvement
noted
 Less potential side effects
 Variable responses
 Nasal confirmation
 Presence of severe discharge
 Compliance

Lymphoplasmacytic rhinitis – Therapy
 Ideally 2-3X per week antiinflammatory and intermittent
antibiotic courses vs. 2-3X/week of both indefinitely or
seasonally
 May consider pulse therapy with antibiotics
 If responsive, most require long term/lifelong therapy
 Compliance is a major issue when patients improve

Bacterial rhinitis - Canine
◦ Pasteurella multocida, Bordatella bronchiseptica may be
primary pathogens - RARE
◦ Last line diagnostic test if no resolution of clinical signs
after treatment of rhinitis

Nasal neoplasia – General considerations
◦ Seen in approximately 1/3 of dogs with chronic nasal disease
◦ Nasal carcinoma 2/3 of all nasal neoplasms
 Adenocarcinoma, undifferentiated, squamous cell
◦ Others = 1/3
 Lymphoma
 Fibrosarcoma
 Neuroendocrine
 Hemangiosarcoma
 MCT
 TVT – extremely rare
◦ Nasal polyps – Rare and typically secondary to inflammation or
underlying neoplasia

Neoplasia – General considerations
◦ Metastasis
 Local lymph nodes
 Lungs – Rare
◦ Most express COX-2 receptors
◦ Clinical signs
 Dramatic
 Unilateral epistaxis and discharge are common
 Facial deformity – other considerations?
 Sporotrichosis, severe aspergillosis
 Angiomatous proliferation of nasal cavity - rare
 Neurologic signs may be very late
 Caudal nasal passage

Nasal neoplasia
◦ Radiographic findings
 Non-specific
 Loss of turbinates
 May see bone lysis
 Fluid in frontal sinus
 Soft tissue opacity late in course of disease
◦ CT
 Very good at determining neoplasia vs. nonneoplastic disease
 Bone erosion/lysis usually consistent with neoplasia
◦ MRI
 Mass effect on MRI not necessarily associated with
neoplasia
 Other factors: cribiform plate erosion, vomer bone
lysis etc. must be present to discriminate
 Bone erosion/lysis usually consistent with neoplasia

Nasal neoplasia
◦ Rhinoscopy
 Sometimes limited by location
 Difficult in most cases due to presence of
hemorrhage, occlusion of nasal passage, and
magnification
 Retroflexion will allow diagnostic specimens in some
◦ Blind biopsy
 Always followed by rhinoscopic assisted biopsies
 Help improve diagnostic accuracy?

Nasal neoplasia
◦ Prognosis - Carcinomas
 No therapy = MST 95d (73-113)
 Epistaxis
 Present = 88d
 Absent = 224d

Nasal neoplasia – Therapy and prognosis
◦ Surgery alone
 Mixed results, but generally disappointing
 MST = 3-6 months
◦ Radiation
 CT planning is best to prevent normal tissue damage
 No evidence that CT planning improves prognosis
 MST = 8-20 months when used alone
◦ IMRT/Cyberknife

Nasal neoplasia – Therapy and prognosis
◦ Radiation followed by surgery
 Best outcome to date
 54 dogs
 4yr MST vs. 2 yr MST with radiation alone in one
study
 More side effects when compared to either alone
 Osteomyelitis
 Fistula formation
 Fungal rhinitis

Nasal neoplasia – Therapy and prognosis
◦ Chemotherapy
 Single agent cisplatin
 MST = 5 months
 Combination adriamycin, carboplatin, piroxicam
 MST is unknown
 Clinical response has been favorable in those in
which it has been used
 81% of canine nasal tumors expressed COX-2
receptors in one study